CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Relationship of mitral valve annulus plane and circumflex‐right coronary artery plane: Implications for transcatheter mitral valve implantation

Samir R. Kapadia MD, Amgad Mentias MD, Amr F. Barakat MD, Mohammad Q. Raza MD, Kanhaiya Lal Poddar MD, Cristian Baeza MD, Gabriel Maluenda MD, Jose Navia MD, Paul Schoenhagen MD, E. Murat Tuzcu MD

Aim: Transcatheter mitral valve implantation (TMVI) is a novel technology for patients with severe mitral valve disease but at high surgical risk. Imaging guidance during the procedure is critical for successful device deployment. Identification of the mitral annular plane (MAP) with fluoroscopy during the procedure is limited by lack of clearly defined landmarks. We hypothesized that a plane defined by left circumflex‐right coronary arteries (LCX‐RCA) would have a consistent relationship to MAP.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. End‐stage renal disease and severe aortic stenosis: Does valve replacement improve one‐year outcomes?

Jose F. Condado MD, MS, Aneel Maini, Bradley Leshnower MD, Vinod Thourani MD, Jessica Forcillo MD, Chandan Devireddy MD, Kreton Mavromatis MD, Eric L. Sarin MD, James Stewart MD, Robert Guyton MD, Amy Simone PA, Patricia Keegan NP, Stamatios Lerakis MD, Peter C. Block MD, Vasilis Babaliaros MD

Background. Treatment for patients with end‐stage renal disease (ESRD) and severe aortic stenosis (AS) includes balloon aortic valvuloplasty (BAV), surgical (SAVR), or transcatheter (TAVR) aortic valve replacement. We compared outcomes among these strategies.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transcatheter closure of patent ductus arteriosus using the AMPLATZER™ duct occluder II (ADO II)

Daniel H. Gruenstein MD, FSCAI, Makram Ebeid MD, FAAP, FACC, FSCAI, Wolfgang Radtke MD, Phillip Moore MD, MBA, Ralf Holzer MD, MSC, FSCAI, Henri Justino MD, CM, FRCPC, FACC, FSCAI

Objectives: The study purpose is to evaluate the safety and efficacy of the ADO II device for closure of patent ductus arteriosus (PDA) in children.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Saphenous vein graft near‐infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near‐infrared spectroscopy (ORACLE‐NIRS) registry

Barbara A. Danek MD, Aris Karatasakis MD, Aya J. Alame BA, Phuong‐Khanh J. Nguyen‐Trong MD, Judit Karacsonyi MD, Bavana Rangan BDS, MPH, Michele Roesle RN, BSN, Amy Atwell LVN, Erica Resendes MS, Jose Roberto Martinez‐Parachini MD, Rahel Iwnetu MD, Pratik Kalsaria MS, Furqan Siddiqui MD, James E. Muller MD, Subhash Banerjee MD, Emmanouil Brilakis MD, PhD

Objectives: We sought to examine near‐infrared spectroscopy (NIRS) imaging findings of aortocoronary saphenous vein grafts (SVGs).

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Accuracy and procedural characteristics of standard needle compared with radiofrequency needle transseptal puncture for structural heart interventions

Gaurav Sharma MD, Gagan D. Singh MD, Thomas W. Smith MD, Dali Fan MD, Reginald I. Low MD, Jason H. Rogers MD

Objectives: Our objectives were to assess for differences between standard and radiofrequency (RF) needle in procedural times, success, and spatial accuracy.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Reduction of radiation exposure during complex interventions for chronic total coronary occlusions: Implementing low dose radiation protocols without affecting procedural success rates

Gerald S. Werner MD, FACC, FESC, FSCAI, Peggy Glaser MD, Anja Coenen MD, Hiller Moehlis MD, Karl‐Heinz Tischer MD, Matthias Koch MD, Reinhold Klingenbeck MD

Background: The increasing complexity of percutaneous coronary intervention (PCI) for chronic total coronary occlusions (CTO) leads to a significant increase of radiation exposure for both patient and operator.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. First prospective multicenter experience with the 7 French Glidesheath slender for complex transradial coronary interventions

Adel Aminian MD, Juan F. Iglesias MD, Carlos Van Mieghem MD, PhD, Andrea Zuffi MD, Angela Ferrara MD, Roukos Manih MD, Dariouch Dolatabadi MD, Jacques Lalmand MD, Shigeru Saito MD, PhD

Purpose: To assess the feasibility and safety of the 7 French (Fr) Glidesheath Slender for complex transradial (TR) percutaneous coronary interventions (PCI).

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transcatheter closure of large atrial septal defects using 40 mm amplatzer septal occluder: Single group experience with short and intermediate term follow‐up

Bharat Dalvi MD, DM, Kshitij Sheth DNB, FNB, Shreepal Jain MD, FNB, Robin Pinto MD, DM

Objectives: To assess feasibility, safety, and efficacy of the use of 40 mm Amplatzer septal occluder (ASO 40) for the closure of large atrial septal defects (ASD).

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Initial clinical experience with the Medtronic Micro Vascular Plug™ in transcatheter occlusion of PDAs in extremely premature infants

Shyam Sathanandam MD, Henri Justino MD, B. Rush Waller III MD, Wolfgang Radtke MD, Athar M. Qureshi MD

Objectives: To describe the early multicenter, clinical experience with the Medtronic Micro Vascular Plug™ (MVP) for the occlusion of patent ductus arteriosus (PDA) in premature infants.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Novel use of the medtronic micro vascular plug for PDA closure in preterm infants

Elizabeth W. Wang‐Giuffre DO, John P. Breinholt MD

Objectives: To describe a single institution experience with a new endovascular occlusion device used for transcatheter patent ductus arteriosus (PDA) closure in preterm infants.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Development and validation of a simple risk score to predict 30‐day readmission after percutaneous coronary intervention in a cohort of medicare patients

Karl E. Minges PhD, MPH, Jeph Herrin PhD, Paul N. Fiorilli MD, Jeptha P. Curtis MD

Objectives: To develop a risk model that can be used to identify PCI patients at higher risk of readmission who may benefit from additional resources at the time of discharge.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality

Jessica Parsh MD, Milan Seth MS, Jacqueline Green MD, Nadia R. Sutton MD, Stanley Chetcuti MD, Simon Dixon MBCHB, Paul M. Grossman MD, Akshay Khandelwal MD, James M. Dupree MD, MPH, Hitinder S. Gurm MD

Objectives: We sought to evaluate the incidence, risk factors, in‐hospital, and long‐term outcomes and predictors of mortality of coronary artery perforations (CAP) in the contemporary percutaneous coronary intervention (PCI) era.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Comparison of a vascular closure device versus the radial approach to reduce access site complications in non‐ST‐segment elevation acute coronary syndrome patients: The angio‐seal versus the radial approach in acute coronary syndrome trial

Pedro B. Andrade MD, PhD, Luiz A. Mattos MD, PhD, Fábio S. Rinaldi MD, Igor C. Bienert MD, PhD, Robson A. Barbosa RN, André Labrunie MD, PhD, Marden Tebet MD, Vinícius Esteves MD, Alexandre Abizaid MD, PhD, Amanda R. Sousa MD, PhD

Objectives: To compare the radial versus femoral approach using Angio‐Seal for the incidence of access site complications among non‐ST‐segment elevation acute coronary syndrome patients undergoing invasive strategy.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials

Georgios Bouras MD, MSC, PhD, Sunny Jhamnani MD, Vivian G. Ng MD, Ido Haimi MD, Vivian Mao MD, Regina Deible RN, Sherry Cao MS, Krishnankutty Sudhir MD, PhD, Alexandra J. Lansky MD

Background. Lesion length has been an important factor in predicting a worse outcome after percutaneous coronary interventions (PCI); however, the safety and efficacy of second‐generation drug eluting stents in very long coronary lesions has not been validated in large scale randomized controlled trials.

Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization

Tae Oh Kim, Do-Yoon Kang, Jung-Min Ahn, Seon Ok Kim, Pil Hyung Lee, Junghoon Lee, Ju Hyeon Kim, Ho Jin Kim, Joon Bum Kim, Suk Jung Choo, Cheol-Hyun Chung, Jae-Won Lee, Seung-Jung Park, Duk-Woo Park, and on behalf of the Asan Medical Center–Multivessel Revascularization Registry Investigators

Background The long-term prognostic impact of mildly decreased renal function in patients undergoing coronary revascularization is still unknown.